750469AA6

Radius Health Inc

Could not find a ticker for this position, may be a filing error

A biopharmaceutical company focused on bone health, best known for TYMLOS, a once-daily injection that builds new bone in people with osteoporosis at high risk of fracture. Founded in 2003, it was taken private in 2022 by investment firms. Its name nods to the radius, the forearm bone often studied in bone-density research.

3% Convertible Notes due 2024

No 8-K or 6-K filings recorded.